News
On Tuesday, Trump Media & Technology Group Corp. (NASDAQ:DJT) rolled out public beta testing of its new AI-powered search ...
Pfizer ( PFE) CEO Albert Bourla said Tuesday he has a "special relationship" with President Trump, cemented during the ...
At first glance, Pfizer delivered a strong Q2 and upped its 2025 full-year EPS guidance. Click here to find out why I rate ...
The twists and turns in U.S. President Donald Trump's tariff policies have not only roiled global financial markets but also ...
Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president ...
In this week’s edition of InnovationRx, we look at a biotech entrepreneur treating a rare genetic disease, new tech aimed at ...
President Trump’s latest tariff threat has targeted a sector that’s already hobbled.
Chief Executive Albert Bourla says he is hopeful about finding a solution in response to Trump’s demand for price cuts.
1don MSN
‘We will work collaboratively’: Big Pharma admits it is discussing Trump’s plan to lower drug prices
Pfizer CEO says drugmakers ‘are all ready to roll up their sleeves and execute’ as president demands more direct-to-consumer ...
The decision effectively cancels projects being led by major pharmaceutical companies, including Pfizer and Moderna.
Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting ...
CEO Albert Bourla said on Tuesday that he and other pharma executives discussed President Donald Trump’s recent call for big pharma to offer direct-to-consumer marketing as part of his Most Favored ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results